J
Joseph F. Boucher
Publications - 2
Citations - 574
Joseph F. Boucher is an academic researcher. The author has contributed to research in topics: Toceranib & Receptor tyrosine kinase. The author has an hindex of 2, co-authored 2 publications receiving 526 citations.
Papers
More filters
Journal ArticleDOI
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision
Cheryl A. London,Phyllis B. Malpas,Stacey L. Wood-Follis,Joseph F. Boucher,Anthony Rusk,Mona P. Rosenberg,Carolyn J. Henry,Kathy L. Mitchener,Mary K. Klein,John G. Hintermeister,Philip J. Bergman,Guillermo Couto,Guy N. Mauldin,Gina M. Michels +13 more
TL;DR: Palladia has biological activity against canine MCTs and can be administered on a continuous schedule without need for routine planned treatment breaks, and shows that spontaneous tumors in dogs are good models to evaluate therapeutic index of targeted therapeutics in a clinical setting.
Journal Article
Phase I Dose-Escalating Study of SU11654, a Small Molecule Receptor Tyrosine Kinase Inhibitor, in Dogs with Spontaneous Malignancies,
Cheryl A. London,Alison L. Hannah,Regina Zadovoskaya,May B. Chien,Cynthia Kollias-Baker,Mona P. Rosenberg,Sue Downing,G. S. Post,Joseph F. Boucher,Narmada Shenoy,Dirk B. Mendel,Gerald McMahon,Julie M. Cherrington +12 more
TL;DR: This study provides the first evidence that p.o. administered kinase inhibitors can exhibit activity against a variety of spontaneous malignancies in dogs, and it is likely that such agents will demonstrate comparable antineoplastic activity in people.